Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management
Forecast
Centers for Disease Control and Prevention - ERA plans to offer grants of up to $725,000 (at least $500,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make about 4 awards worth $10.0 million in total. It is a forecast: the notice is expected around January 21, 2027, with applications due around March 22, 2027.
From the official notice on Grants.gov, last changed September 22, 2026. Checked October 31, 2026.
- Award ceiling$725,000
- Award floor$500,000
- Expected awards4
- Total funding$10.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | July 28, 2026 |
|---|---|
| Expected posting | January 21, 2027 |
| Expected deadline | March 22, 2027 |
| Expected award date | August 30, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
Diabetes causes illness and death in the United States. It leads to high health care costs. People who use Federally Qualified Health Centers (FQHCs) and other safety-net clinics face greater risks. Many community-clinical linkage (CCL) strategies show benefits when used alone. We know less about how several strategies can be combined and coordinated. Using multiple strategies together may improve diabetes prevention and management in primary care. This NOFO aims to find what helps or blocks the use of coordinated CCL strategies. We will identify factors that affect adoption, integration, and long-term success. Researchers will study real-world FHQC clinics. Practical evidence will guide best practices for diabetes prevention and management.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Natalie Brown, MPH, researchnofo@cdc.gov, 404-639-4601.
Questions people ask
Who can apply for Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management?
Centers for Disease Control and Prevention - ERA accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
What is the deadline for Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management?
Expected deadline March 22, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $725,000 each. About $10.0 million in total across about 4 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience